 Kristi Anseth
Concepts (704)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 166 | 2025 | 679 | 28.080 |
Why?
| | Polyethylene Glycols | 122 | 2025 | 632 | 18.160 |
Why?
| | Biocompatible Materials | 85 | 2025 | 424 | 11.940 |
Why?
| | Extracellular Matrix | 60 | 2025 | 535 | 10.160 |
Why?
| | Tissue Engineering | 56 | 2023 | 427 | 7.660 |
Why?
| | Myofibroblasts | 19 | 2025 | 127 | 6.930 |
Why?
| | Cell Culture Techniques | 34 | 2023 | 363 | 6.190 |
Why?
| | Aortic Valve | 25 | 2025 | 351 | 6.100 |
Why?
| | Chondrocytes | 24 | 2021 | 226 | 4.980 |
Why?
| | Polymers | 47 | 2024 | 490 | 4.810 |
Why?
| | Elasticity | 19 | 2024 | 198 | 4.670 |
Why?
| | Heart Valves | 14 | 2019 | 42 | 4.550 |
Why?
| | Sulfhydryl Compounds | 20 | 2025 | 188 | 4.480 |
Why?
| | Organoids | 9 | 2025 | 120 | 4.430 |
Why?
| | Mechanotransduction, Cellular | 10 | 2024 | 111 | 4.300 |
Why?
| | Calcinosis | 12 | 2025 | 235 | 4.210 |
Why?
| | Cells, Cultured | 80 | 2025 | 4160 | 4.180 |
Why?
| | Fibroblasts | 21 | 2025 | 1002 | 4.140 |
Why?
| | Aortic Valve Stenosis | 10 | 2025 | 231 | 4.060 |
Why?
| | Cross-Linking Reagents | 35 | 2025 | 215 | 3.810 |
Why?
| | Cell Differentiation | 34 | 2024 | 1999 | 3.220 |
Why?
| | Osteogenesis | 15 | 2020 | 196 | 3.220 |
Why?
| | Oligopeptides | 19 | 2024 | 270 | 3.190 |
Why?
| | Hydrazones | 7 | 2024 | 25 | 3.020 |
Why?
| | Tissue Scaffolds | 18 | 2024 | 212 | 3.010 |
Why?
| | Cell Survival | 37 | 2024 | 1130 | 2.820 |
Why?
| | Click Chemistry | 10 | 2021 | 50 | 2.740 |
Why?
| | Photochemistry | 34 | 2021 | 133 | 2.740 |
Why?
| | Swine | 35 | 2022 | 796 | 2.740 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 17 | 2016 | 77 | 2.650 |
Why?
| | Osteoblasts | 14 | 2025 | 130 | 2.640 |
Why?
| | Biomimetic Materials | 11 | 2018 | 71 | 2.510 |
Why?
| | Animals | 142 | 2025 | 37151 | 2.490 |
Why?
| | Intestines | 5 | 2025 | 354 | 2.270 |
Why?
| | Photolysis | 10 | 2025 | 93 | 2.250 |
Why?
| | Cellular Microenvironment | 7 | 2022 | 84 | 2.250 |
Why?
| | Light | 22 | 2020 | 390 | 2.220 |
Why?
| | Peptides | 15 | 2015 | 980 | 2.040 |
Why?
| | Drug Delivery Systems | 15 | 2024 | 357 | 2.040 |
Why?
| | Cartilage | 13 | 2018 | 192 | 2.020 |
Why?
| | Materials Testing | 34 | 2019 | 349 | 2.010 |
Why?
| | Cell Adhesion | 22 | 2014 | 465 | 1.900 |
Why?
| | Cell Movement | 11 | 2024 | 971 | 1.860 |
Why?
| | Photochemical Processes | 13 | 2024 | 108 | 1.850 |
Why?
| | Transforming Growth Factor beta1 | 12 | 2020 | 165 | 1.790 |
Why?
| | Cell Communication | 10 | 2016 | 315 | 1.760 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2024 | 218 | 1.730 |
Why?
| | Acrylic Resins | 3 | 2025 | 46 | 1.730 |
Why?
| | Proteins | 7 | 2023 | 1011 | 1.680 |
Why?
| | Esters | 6 | 2025 | 77 | 1.660 |
Why?
| | Matrix Metalloproteinases | 9 | 2017 | 96 | 1.660 |
Why?
| | Cartilage, Articular | 8 | 2021 | 330 | 1.590 |
Why?
| | Collagen | 14 | 2021 | 454 | 1.530 |
Why?
| | Actins | 16 | 2022 | 418 | 1.520 |
Why?
| | Insulin-Secreting Cells | 7 | 2014 | 377 | 1.450 |
Why?
| | Microscopy | 2 | 2023 | 155 | 1.390 |
Why?
| | Myoblasts | 6 | 2024 | 82 | 1.350 |
Why?
| | Azides | 5 | 2022 | 47 | 1.310 |
Why?
| | Mice | 51 | 2025 | 17769 | 1.310 |
Why?
| | Melanoma | 4 | 2021 | 763 | 1.300 |
Why?
| | Fibrosis | 8 | 2025 | 544 | 1.290 |
Why?
| | Hyaluronic Acid | 6 | 2024 | 226 | 1.290 |
Why?
| | Molecular Structure | 22 | 2025 | 495 | 1.240 |
Why?
| | Paracrine Communication | 3 | 2020 | 66 | 1.220 |
Why?
| | Cells, Immobilized | 7 | 2018 | 21 | 1.190 |
Why?
| | Islets of Langerhans | 7 | 2010 | 793 | 1.150 |
Why?
| | Polymerization | 8 | 2025 | 128 | 1.140 |
Why?
| | Cadherins | 3 | 2022 | 201 | 1.130 |
Why?
| | Humans | 113 | 2025 | 138102 | 1.110 |
Why?
| | Signal Transduction | 15 | 2022 | 5068 | 1.100 |
Why?
| | Coated Materials, Biocompatible | 5 | 2011 | 64 | 1.100 |
Why?
| | Anhydrides | 8 | 2010 | 18 | 1.100 |
Why?
| | Fibroblast Growth Factor 2 | 5 | 2008 | 87 | 1.080 |
Why?
| | Extracellular Matrix Proteins | 4 | 2013 | 155 | 1.080 |
Why?
| | Phenotype | 12 | 2025 | 3158 | 1.080 |
Why?
| | Viscosity | 5 | 2024 | 92 | 1.060 |
Why?
| | Cell Line | 16 | 2025 | 2865 | 1.060 |
Why?
| | Elastic Modulus | 8 | 2017 | 123 | 1.040 |
Why?
| | Gels | 9 | 2008 | 79 | 1.040 |
Why?
| | Cell Proliferation | 21 | 2025 | 2472 | 1.040 |
Why?
| | Serum | 3 | 2022 | 60 | 1.040 |
Why?
| | Capsules | 7 | 2019 | 39 | 1.030 |
Why?
| | Spheroids, Cellular | 3 | 2017 | 75 | 1.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 6 | 2021 | 430 | 1.010 |
Why?
| | Acrylates | 12 | 2025 | 47 | 1.010 |
Why?
| | Indoles | 4 | 2017 | 408 | 1.010 |
Why?
| | Integrins | 3 | 2024 | 95 | 1.000 |
Why?
| | Gene Expression | 9 | 2022 | 1487 | 0.990 |
Why?
| | Transforming Growth Factor beta | 6 | 2024 | 487 | 0.970 |
Why?
| | Sulfides | 4 | 2022 | 82 | 0.960 |
Why?
| | Islets of Langerhans Transplantation | 4 | 2010 | 64 | 0.960 |
Why?
| | Allyl Compounds | 3 | 2022 | 22 | 0.950 |
Why?
| | Triazoles | 2 | 2024 | 152 | 0.950 |
Why?
| | Sus scrofa | 6 | 2020 | 57 | 0.940 |
Why?
| | Heparin | 6 | 2010 | 251 | 0.910 |
Why?
| | Mechanical Phenomena | 3 | 2019 | 84 | 0.890 |
Why?
| | Staphylococcus epidermidis | 3 | 2010 | 77 | 0.880 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2024 | 29 | 0.880 |
Why?
| | Vancomycin | 3 | 2010 | 79 | 0.870 |
Why?
| | Actomyosin | 1 | 2024 | 21 | 0.870 |
Why?
| | Kinetics | 21 | 2020 | 1640 | 0.860 |
Why?
| | Heart Valve Diseases | 3 | 2014 | 149 | 0.860 |
Why?
| | Rheology | 7 | 2024 | 93 | 0.860 |
Why?
| | Bone Regeneration | 4 | 2020 | 26 | 0.840 |
Why?
| | Collagenases | 3 | 2015 | 24 | 0.840 |
Why?
| | PTEN Phosphohydrolase | 1 | 2025 | 163 | 0.840 |
Why?
| | Regenerative Medicine | 2 | 2017 | 52 | 0.830 |
Why?
| | Norbornanes | 3 | 2013 | 14 | 0.810 |
Why?
| | Polyesters | 6 | 2009 | 77 | 0.800 |
Why?
| | Bone Substitutes | 5 | 2019 | 27 | 0.800 |
Why?
| | Delayed-Action Preparations | 10 | 2018 | 173 | 0.790 |
Why?
| | Sulfonamides | 3 | 2017 | 510 | 0.770 |
Why?
| | Peptide Fragments | 4 | 2013 | 691 | 0.760 |
Why?
| | Alkynes | 5 | 2022 | 57 | 0.750 |
Why?
| | Genes, X-Linked | 1 | 2022 | 20 | 0.740 |
Why?
| | Podosomes | 1 | 2021 | 4 | 0.740 |
Why?
| | Cattle | 19 | 2018 | 987 | 0.740 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2022 | 42 | 0.740 |
Why?
| | X Chromosome Inactivation | 1 | 2022 | 24 | 0.740 |
Why?
| | Rats | 26 | 2022 | 5564 | 0.730 |
Why?
| | Fibronectins | 7 | 2012 | 132 | 0.730 |
Why?
| | Elastomers | 1 | 2021 | 29 | 0.710 |
Why?
| | Stress, Mechanical | 9 | 2021 | 483 | 0.710 |
Why?
| | Skull | 5 | 2012 | 145 | 0.710 |
Why?
| | NIH 3T3 Cells | 11 | 2020 | 146 | 0.700 |
Why?
| | Coculture Techniques | 7 | 2024 | 240 | 0.690 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1239 | 0.690 |
Why?
| | Chondrogenesis | 4 | 2011 | 87 | 0.690 |
Why?
| | Dexamethasone | 4 | 2013 | 365 | 0.690 |
Why?
| | Intestinal Mucosa | 5 | 2023 | 621 | 0.680 |
Why?
| | Bone and Bones | 5 | 2019 | 318 | 0.680 |
Why?
| | Mechanoreceptors | 1 | 2020 | 17 | 0.670 |
Why?
| | Myocytes, Cardiac | 5 | 2020 | 505 | 0.670 |
Why?
| | Calcium Signaling | 2 | 2020 | 249 | 0.670 |
Why?
| | Inflammation Mediators | 2 | 2020 | 511 | 0.660 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 102 | 0.660 |
Why?
| | Fluorescent Dyes | 5 | 2015 | 318 | 0.640 |
Why?
| | Models, Biological | 9 | 2024 | 1784 | 0.640 |
Why?
| | Phosphates | 3 | 2012 | 180 | 0.630 |
Why?
| | Tumor Microenvironment | 4 | 2024 | 668 | 0.630 |
Why?
| | Drug Carriers | 7 | 2017 | 126 | 0.630 |
Why?
| | Regeneration | 4 | 2016 | 198 | 0.630 |
Why?
| | Models, Chemical | 8 | 2009 | 269 | 0.630 |
Why?
| | Anthracenes | 1 | 2019 | 32 | 0.620 |
Why?
| | Methacrylates | 6 | 2012 | 117 | 0.610 |
Why?
| | Proteoglycans | 3 | 2013 | 110 | 0.600 |
Why?
| | Osteoporosis | 1 | 2022 | 244 | 0.600 |
Why?
| | Biophysics | 1 | 2019 | 71 | 0.600 |
Why?
| | Azo Compounds | 2 | 2018 | 29 | 0.600 |
Why?
| | Cyclooctanes | 1 | 2018 | 5 | 0.590 |
Why?
| | Aza Compounds | 1 | 2018 | 13 | 0.590 |
Why?
| | Viscoelastic Substances | 2 | 2020 | 10 | 0.590 |
Why?
| | Lactic Acid | 6 | 2016 | 308 | 0.580 |
Why?
| | Surface Properties | 12 | 2012 | 411 | 0.580 |
Why?
| | Peptides, Cyclic | 2 | 2010 | 265 | 0.580 |
Why?
| | Pulmonary Alveoli | 3 | 2017 | 405 | 0.570 |
Why?
| | Transcriptome | 5 | 2022 | 969 | 0.560 |
Why?
| | Alkaline Phosphatase | 8 | 2016 | 151 | 0.560 |
Why?
| | Precision Medicine | 2 | 2022 | 420 | 0.550 |
Why?
| | Proto-Oncogene Proteins B-raf | 2 | 2021 | 222 | 0.550 |
Why?
| | Molecular Probes | 1 | 2017 | 35 | 0.540 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 131 | 0.540 |
Why?
| | Myocardium | 5 | 2024 | 900 | 0.540 |
Why?
| | Cell Line, Tumor | 11 | 2024 | 3404 | 0.530 |
Why?
| | Cycloaddition Reaction | 6 | 2024 | 28 | 0.520 |
Why?
| | Antigens | 3 | 2013 | 356 | 0.520 |
Why?
| | Biopolymers | 3 | 2022 | 31 | 0.510 |
Why?
| | Insulin | 9 | 2014 | 2405 | 0.510 |
Why?
| | DNA | 6 | 2006 | 1448 | 0.510 |
Why?
| | Apoptosis | 10 | 2017 | 2555 | 0.510 |
Why?
| | Macromolecular Substances | 3 | 2017 | 227 | 0.500 |
Why?
| | Lipase | 2 | 2007 | 69 | 0.500 |
Why?
| | Cell Self Renewal | 1 | 2016 | 56 | 0.490 |
Why?
| | Polyvinyl Alcohol | 5 | 2002 | 18 | 0.490 |
Why?
| | Amino Acid Sequence | 7 | 2015 | 2159 | 0.490 |
Why?
| | Gene Expression Regulation | 8 | 2022 | 2586 | 0.480 |
Why?
| | Microspheres | 2 | 2015 | 134 | 0.480 |
Why?
| | 3T3 Cells | 5 | 2012 | 164 | 0.480 |
Why?
| | Nanoparticles | 3 | 2018 | 468 | 0.480 |
Why?
| | Muscle, Smooth | 4 | 2009 | 151 | 0.480 |
Why?
| | Microarray Analysis | 1 | 2015 | 116 | 0.470 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2012 | 73 | 0.460 |
Why?
| | Niacinamide | 1 | 2015 | 82 | 0.440 |
Why?
| | Solubility | 5 | 2020 | 241 | 0.440 |
Why?
| | Phenylurea Compounds | 1 | 2015 | 97 | 0.440 |
Why?
| | Rats, Sprague-Dawley | 11 | 2022 | 2472 | 0.440 |
Why?
| | Macrophages | 2 | 2020 | 1544 | 0.430 |
Why?
| | Immobilized Proteins | 1 | 2014 | 10 | 0.430 |
Why?
| | Laminin | 4 | 2025 | 72 | 0.430 |
Why?
| | Immunohistochemistry | 7 | 2022 | 1718 | 0.430 |
Why?
| | Microscopy, Confocal | 4 | 2012 | 322 | 0.430 |
Why?
| | Factor XIIIa | 1 | 2013 | 5 | 0.420 |
Why?
| | Staphylococcal Infections | 2 | 2009 | 386 | 0.420 |
Why?
| | Antibodies | 2 | 2006 | 406 | 0.420 |
Why?
| | Mammals | 3 | 2023 | 287 | 0.420 |
Why?
| | Protein Kinase Inhibitors | 2 | 2021 | 905 | 0.420 |
Why?
| | Cell Engineering | 1 | 2013 | 14 | 0.420 |
Why?
| | Biochemistry | 1 | 2014 | 38 | 0.420 |
Why?
| | Prostheses and Implants | 5 | 2009 | 141 | 0.410 |
Why?
| | Serum Albumin, Bovine | 2 | 2018 | 66 | 0.410 |
Why?
| | Microfluidics | 3 | 2010 | 56 | 0.410 |
Why?
| | Epithelial Cells | 4 | 2022 | 1100 | 0.400 |
Why?
| | Compressive Strength | 5 | 2021 | 76 | 0.400 |
Why?
| | beta Catenin | 1 | 2015 | 252 | 0.390 |
Why?
| | Orthopedics | 4 | 2007 | 153 | 0.390 |
Why?
| | Polystyrenes | 5 | 2014 | 36 | 0.390 |
Why?
| | Stem Cells | 3 | 2022 | 598 | 0.390 |
Why?
| | Biomarkers | 5 | 2022 | 4111 | 0.380 |
Why?
| | Nanocapsules | 1 | 2012 | 14 | 0.380 |
Why?
| | Cytokines | 1 | 2020 | 2079 | 0.380 |
Why?
| | Leukocyte Elastase | 2 | 2009 | 75 | 0.380 |
Why?
| | Microfluidic Analytical Techniques | 4 | 2018 | 76 | 0.380 |
Why?
| | Time Factors | 14 | 2011 | 6845 | 0.370 |
Why?
| | Molecular Weight | 5 | 2014 | 331 | 0.370 |
Why?
| | Disease Progression | 3 | 2021 | 2730 | 0.360 |
Why?
| | Muscle Contraction | 3 | 2024 | 438 | 0.360 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 329 | 0.360 |
Why?
| | Biomechanical Phenomena | 6 | 2017 | 815 | 0.350 |
Why?
| | Cardiomegaly | 2 | 2024 | 166 | 0.350 |
Why?
| | Nerve Net | 1 | 2014 | 265 | 0.350 |
Why?
| | TRPV Cation Channels | 2 | 2022 | 41 | 0.350 |
Why?
| | Embryonic Stem Cells | 2 | 2014 | 129 | 0.350 |
Why?
| | Awards and Prizes | 1 | 2012 | 72 | 0.350 |
Why?
| | Printing, Three-Dimensional | 2 | 2022 | 90 | 0.350 |
Why?
| | Tensile Strength | 5 | 2025 | 95 | 0.350 |
Why?
| | Endothelial Cells | 2 | 2014 | 786 | 0.340 |
Why?
| | Culture Media | 4 | 2014 | 164 | 0.340 |
Why?
| | MAP Kinase Signaling System | 3 | 2021 | 322 | 0.340 |
Why?
| | Gelatin | 2 | 2017 | 53 | 0.340 |
Why?
| | Metalloporphyrins | 1 | 2011 | 105 | 0.340 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 979 | 0.340 |
Why?
| | Titanium | 2 | 2010 | 82 | 0.340 |
Why?
| | Superoxides | 1 | 2011 | 217 | 0.340 |
Why?
| | Organ Culture Techniques | 1 | 2010 | 156 | 0.330 |
Why?
| | Collagen Type I | 4 | 2020 | 138 | 0.330 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2010 | 17 | 0.330 |
Why?
| | Fibrosarcoma | 1 | 2009 | 20 | 0.320 |
Why?
| | Prosthesis-Related Infections | 2 | 2009 | 98 | 0.320 |
Why?
| | Phosphinic Acids | 1 | 2009 | 9 | 0.320 |
Why?
| | fas Receptor | 1 | 2010 | 96 | 0.320 |
Why?
| | Equipment Design | 4 | 2017 | 510 | 0.320 |
Why?
| | Anti-Bacterial Agents | 2 | 2010 | 1804 | 0.310 |
Why?
| | Pravastatin | 1 | 2009 | 41 | 0.310 |
Why?
| | Cardiomyopathies | 1 | 2013 | 324 | 0.310 |
Why?
| | Parathyroid Hormone | 2 | 2020 | 111 | 0.310 |
Why?
| | Phosphoproteins | 3 | 2017 | 340 | 0.310 |
Why?
| | Recombinant Proteins | 5 | 2012 | 1349 | 0.310 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 116 | 0.310 |
Why?
| | Plasmids | 4 | 2007 | 359 | 0.310 |
Why?
| | Transcription Factors | 4 | 2021 | 1709 | 0.310 |
Why?
| | Magnetic Resonance Spectroscopy | 7 | 2009 | 616 | 0.310 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2925 | 0.300 |
Why?
| | Heart Valve Prosthesis | 3 | 2005 | 112 | 0.300 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 352 | 0.300 |
Why?
| | Enzymes | 1 | 2009 | 65 | 0.300 |
Why?
| | Bioprinting | 2 | 2022 | 30 | 0.300 |
Why?
| | Sex Characteristics | 3 | 2025 | 770 | 0.300 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2009 | 60 | 0.300 |
Why?
| | Heart Defects, Congenital | 2 | 2014 | 840 | 0.300 |
Why?
| | Trans-Activators | 3 | 2021 | 395 | 0.290 |
Why?
| | In Vitro Techniques | 5 | 2014 | 1088 | 0.290 |
Why?
| | Protein Engineering | 2 | 2008 | 107 | 0.290 |
Why?
| | Dendritic Cells | 1 | 2012 | 491 | 0.290 |
Why?
| | Polyhydroxyethyl Methacrylate | 3 | 2007 | 10 | 0.290 |
Why?
| | Cell Division | 5 | 2004 | 790 | 0.290 |
Why?
| | Hemodynamics | 1 | 2013 | 1076 | 0.290 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2009 | 134 | 0.280 |
Why?
| | Transfection | 5 | 2011 | 938 | 0.280 |
Why?
| | Glucocorticoids | 1 | 2012 | 528 | 0.280 |
Why?
| | Smad Proteins | 1 | 2008 | 43 | 0.280 |
Why?
| | Glucose Oxidase | 4 | 2011 | 26 | 0.280 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 498 | 0.280 |
Why?
| | Microscopy, Electron, Scanning | 7 | 2012 | 198 | 0.280 |
Why?
| | High-Throughput Screening Assays | 2 | 2025 | 157 | 0.280 |
Why?
| | Protein Binding | 6 | 2010 | 2232 | 0.280 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1983 | 0.280 |
Why?
| | Bone Cements | 2 | 2010 | 42 | 0.280 |
Why?
| | Biofilms | 1 | 2010 | 264 | 0.280 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 648 | 0.270 |
Why?
| | Ultraviolet Rays | 5 | 2009 | 397 | 0.270 |
Why?
| | Anoikis | 1 | 2007 | 31 | 0.260 |
Why?
| | Glucose | 6 | 2014 | 1033 | 0.260 |
Why?
| | Collagen Type II | 4 | 2009 | 54 | 0.260 |
Why?
| | Temperature | 5 | 2013 | 673 | 0.260 |
Why?
| | Aorta | 1 | 2009 | 417 | 0.260 |
Why?
| | Shear Strength | 2 | 2020 | 68 | 0.260 |
Why?
| | Growth Substances | 3 | 2003 | 148 | 0.250 |
Why?
| | Students | 1 | 2012 | 627 | 0.250 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2006 | 55 | 0.250 |
Why?
| | Adsorption | 4 | 2012 | 150 | 0.250 |
Why?
| | Cell Shape | 3 | 2022 | 57 | 0.250 |
Why?
| | Nerve Tissue | 1 | 2005 | 7 | 0.240 |
Why?
| | Biology | 2 | 2017 | 91 | 0.240 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 3 | 2014 | 42 | 0.240 |
Why?
| | Cell Nucleus | 2 | 2020 | 612 | 0.240 |
Why?
| | Extracellular Fluid | 1 | 2005 | 31 | 0.240 |
Why?
| | Porosity | 2 | 2019 | 101 | 0.230 |
Why?
| | Biodegradation, Environmental | 6 | 2003 | 87 | 0.230 |
Why?
| | Staining and Labeling | 3 | 2015 | 155 | 0.230 |
Why?
| | Carbonates | 1 | 2025 | 11 | 0.230 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2005 | 16 | 0.230 |
Why?
| | Chromosomes, Human, Y | 1 | 2025 | 25 | 0.230 |
Why?
| | Cell Separation | 2 | 2018 | 316 | 0.230 |
Why?
| | Bioprosthesis | 1 | 2005 | 40 | 0.230 |
Why?
| | Calcium | 4 | 2024 | 1183 | 0.230 |
Why?
| | Microscopy, Atomic Force | 3 | 2017 | 126 | 0.230 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 451 | 0.230 |
Why?
| | PAX7 Transcription Factor | 1 | 2024 | 13 | 0.230 |
Why?
| | MicroRNAs | 1 | 2011 | 678 | 0.220 |
Why?
| | Carbamates | 1 | 2025 | 50 | 0.220 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 854 | 0.220 |
Why?
| | Polyanhydrides | 1 | 2004 | 2 | 0.220 |
Why?
| | Guided Tissue Regeneration | 1 | 2004 | 13 | 0.220 |
Why?
| | Primary Cell Culture | 3 | 2016 | 172 | 0.220 |
Why?
| | Cell Membrane | 3 | 2013 | 713 | 0.220 |
Why?
| | Vesiculovirus | 1 | 2024 | 17 | 0.220 |
Why?
| | Ultrasonography | 1 | 2008 | 774 | 0.220 |
Why?
| | Anisotropy | 1 | 2024 | 77 | 0.220 |
Why?
| | Organophosphates | 1 | 2005 | 155 | 0.220 |
Why?
| | Diffusion | 4 | 2009 | 120 | 0.220 |
Why?
| | Boidae | 1 | 2024 | 22 | 0.210 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 4 | 2010 | 86 | 0.210 |
Why?
| | Cell Transplantation | 1 | 2003 | 38 | 0.210 |
Why?
| | Nitrites | 1 | 2004 | 86 | 0.210 |
Why?
| | Azacitidine | 1 | 2025 | 140 | 0.210 |
Why?
| | Chemistry, Pharmaceutical | 2 | 2017 | 104 | 0.210 |
Why?
| | Microscopy, Fluorescence | 3 | 2012 | 413 | 0.200 |
Why?
| | Aldehydes | 2 | 2014 | 144 | 0.200 |
Why?
| | Drug Design | 3 | 2012 | 165 | 0.200 |
Why?
| | Cell Cycle | 2 | 2019 | 600 | 0.200 |
Why?
| | Endoglin | 2 | 2016 | 18 | 0.200 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3301 | 0.200 |
Why?
| | Butadienes | 1 | 2003 | 37 | 0.200 |
Why?
| | Weight-Bearing | 1 | 2004 | 173 | 0.200 |
Why?
| | Annexin A2 | 1 | 2022 | 16 | 0.200 |
Why?
| | Axons | 2 | 2014 | 196 | 0.200 |
Why?
| | Calcification, Physiologic | 1 | 2002 | 33 | 0.190 |
Why?
| | Male | 17 | 2025 | 67984 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2012 | 2022 | 0.190 |
Why?
| | Mice, Inbred BALB C | 3 | 2010 | 1260 | 0.190 |
Why?
| | Hydrolysis | 5 | 2025 | 194 | 0.190 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 27 | 0.190 |
Why?
| | Particle Size | 4 | 2012 | 391 | 0.190 |
Why?
| | Interstitial Cells of Cajal | 2 | 2019 | 3 | 0.190 |
Why?
| | Receptors, Cell Surface | 3 | 2008 | 392 | 0.180 |
Why?
| | Neurons | 3 | 2010 | 1593 | 0.180 |
Why?
| | Morphogenesis | 1 | 2023 | 169 | 0.180 |
Why?
| | Robotics | 1 | 2023 | 85 | 0.180 |
Why?
| | Mice, Nude | 4 | 2015 | 690 | 0.180 |
Why?
| | Osteopontin | 3 | 2006 | 32 | 0.180 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1755 | 0.180 |
Why?
| | Ovariectomy | 1 | 2022 | 155 | 0.180 |
Why?
| | Sex Factors | 3 | 2022 | 2071 | 0.180 |
Why?
| | Organogenesis | 1 | 2022 | 60 | 0.180 |
Why?
| | Base Sequence | 4 | 2012 | 2180 | 0.180 |
Why?
| | Drug Compounding | 4 | 2005 | 101 | 0.180 |
Why?
| | Isoelectric Point | 1 | 2021 | 24 | 0.180 |
Why?
| | Glycosaminoglycans | 4 | 2008 | 81 | 0.170 |
Why?
| | Vinculin | 2 | 2013 | 10 | 0.170 |
Why?
| | Temporomandibular Joint | 1 | 2001 | 9 | 0.170 |
Why?
| | Focal Adhesions | 2 | 2015 | 44 | 0.170 |
Why?
| | Sialoglycoproteins | 3 | 2006 | 159 | 0.170 |
Why?
| | Isoproterenol | 1 | 2021 | 101 | 0.170 |
Why?
| | Membrane Proteins | 2 | 2020 | 1154 | 0.170 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2021 | 66 | 0.170 |
Why?
| | Muramidase | 2 | 2012 | 81 | 0.170 |
Why?
| | THP-1 Cells | 1 | 2020 | 19 | 0.170 |
Why?
| | Secretory Pathway | 1 | 2020 | 8 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2025 | 748 | 0.170 |
Why?
| | Tricarboxylic Acids | 1 | 2000 | 10 | 0.170 |
Why?
| | Chromatography, Gel | 3 | 2007 | 130 | 0.170 |
Why?
| | Bacterial Adhesion | 2 | 2012 | 101 | 0.160 |
Why?
| | Hydroxamic Acids | 1 | 2020 | 89 | 0.160 |
Why?
| | Fluoresceins | 2 | 2012 | 49 | 0.160 |
Why?
| | Viral Proteins | 2 | 2024 | 361 | 0.160 |
Why?
| | Wound Healing | 4 | 2022 | 343 | 0.160 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2017 | 131 | 0.160 |
Why?
| | DNA Methylation | 1 | 2025 | 641 | 0.160 |
Why?
| | Hexanes | 1 | 1999 | 4 | 0.160 |
Why?
| | Acetylation | 1 | 2020 | 245 | 0.160 |
Why?
| | Dicarboxylic Acids | 1 | 1999 | 9 | 0.160 |
Why?
| | Photosensitizing Agents | 1 | 2000 | 39 | 0.160 |
Why?
| | DNA Primers | 3 | 2012 | 508 | 0.160 |
Why?
| | Boronic Acids | 1 | 2019 | 35 | 0.160 |
Why?
| | Adipogenesis | 2 | 2011 | 57 | 0.160 |
Why?
| | Ligands | 2 | 2014 | 666 | 0.150 |
Why?
| | Bone Diseases | 1 | 2019 | 63 | 0.150 |
Why?
| | Antibodies, Immobilized | 1 | 2018 | 2 | 0.150 |
Why?
| | Free Radicals | 2 | 2025 | 113 | 0.150 |
Why?
| | Isomerism | 2 | 2018 | 55 | 0.150 |
Why?
| | Histone Deacetylases | 1 | 2020 | 211 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2020 | 208 | 0.150 |
Why?
| | Receptors, Fibroblast Growth Factor | 2 | 2010 | 68 | 0.150 |
Why?
| | Bioengineering | 1 | 2018 | 20 | 0.150 |
Why?
| | Phenylacetates | 1 | 2018 | 9 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 442 | 0.140 |
Why?
| | DNA Ligases | 1 | 2018 | 7 | 0.140 |
Why?
| | Equipment Failure Analysis | 2 | 2017 | 130 | 0.140 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 84 | 0.140 |
Why?
| | Gold | 1 | 2019 | 118 | 0.140 |
Why?
| | Jurkat Cells | 2 | 2010 | 138 | 0.140 |
Why?
| | Bacteriophage T4 | 1 | 2018 | 15 | 0.140 |
Why?
| | Absorbable Implants | 2 | 2009 | 36 | 0.140 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2018 | 79 | 0.140 |
Why?
| | Chemotaxis | 2 | 2009 | 132 | 0.140 |
Why?
| | beta-Cyclodextrins | 1 | 2018 | 28 | 0.140 |
Why?
| | Female | 13 | 2025 | 73648 | 0.140 |
Why?
| | Dendrimers | 1 | 2017 | 18 | 0.140 |
Why?
| | Heart Diseases | 1 | 2021 | 331 | 0.140 |
Why?
| | Absorption | 2 | 2009 | 60 | 0.140 |
Why?
| | Animals, Newborn | 3 | 2006 | 847 | 0.140 |
Why?
| | A549 Cells | 1 | 2017 | 72 | 0.140 |
Why?
| | Heart | 1 | 2021 | 611 | 0.140 |
Why?
| | Periodicals as Topic | 2 | 2017 | 212 | 0.130 |
Why?
| | Substrate Specificity | 2 | 2009 | 385 | 0.130 |
Why?
| | Biomimetics | 1 | 2017 | 43 | 0.130 |
Why?
| | Biomedical Engineering | 4 | 2001 | 27 | 0.130 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 48 | 0.130 |
Why?
| | Enzyme Stability | 2 | 2018 | 73 | 0.130 |
Why?
| | Rubber | 1 | 1996 | 7 | 0.130 |
Why?
| | Culture Media, Serum-Free | 2 | 2007 | 46 | 0.130 |
Why?
| | Elastin | 2 | 2008 | 78 | 0.130 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 158 | 0.130 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 501 | 0.120 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2017 | 193 | 0.120 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2008 | 557 | 0.120 |
Why?
| | Maleimides | 2 | 2013 | 21 | 0.120 |
Why?
| | Antigens, Neoplasm | 1 | 2018 | 317 | 0.120 |
Why?
| | Furans | 2 | 2013 | 24 | 0.120 |
Why?
| | Stromal Cells | 1 | 2015 | 111 | 0.120 |
Why?
| | Nanomedicine | 1 | 2016 | 45 | 0.120 |
Why?
| | Composite Resins | 1 | 1996 | 107 | 0.120 |
Why?
| | Structure-Activity Relationship | 2 | 2009 | 568 | 0.120 |
Why?
| | Models, Theoretical | 4 | 2007 | 583 | 0.120 |
Why?
| | Medicine | 1 | 2017 | 126 | 0.110 |
Why?
| | Hot Temperature | 1 | 2018 | 394 | 0.110 |
Why?
| | Histones | 1 | 2020 | 636 | 0.110 |
Why?
| | Ethylene Glycols | 3 | 2000 | 16 | 0.110 |
Why?
| | Electrophoresis, Agar Gel | 2 | 2004 | 26 | 0.110 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4309 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 461 | 0.110 |
Why?
| | Cell-Matrix Junctions | 1 | 2014 | 2 | 0.110 |
Why?
| | Cytostatic Agents | 1 | 2014 | 6 | 0.110 |
Why?
| | Streptavidin | 1 | 2014 | 14 | 0.110 |
Why?
| | Computational Biology | 2 | 2022 | 649 | 0.110 |
Why?
| | Glass | 1 | 2014 | 44 | 0.110 |
Why?
| | Integrin beta1 | 1 | 2013 | 24 | 0.110 |
Why?
| | Acyltransferases | 1 | 2014 | 56 | 0.110 |
Why?
| | Benzaldehydes | 1 | 2013 | 10 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2013 | 42 | 0.110 |
Why?
| | Cyclization | 2 | 2011 | 20 | 0.100 |
Why?
| | Basal Metabolism | 1 | 2014 | 61 | 0.100 |
Why?
| | Stage-Specific Embryonic Antigens | 1 | 2013 | 2 | 0.100 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2019 | 174 | 0.100 |
Why?
| | CD146 Antigen | 1 | 2013 | 42 | 0.100 |
Why?
| | Benzoquinones | 1 | 2014 | 48 | 0.100 |
Why?
| | Biophysical Phenomena | 1 | 2013 | 64 | 0.100 |
Why?
| | Coloring Agents | 1 | 2013 | 87 | 0.100 |
Why?
| | Muscle Cells | 1 | 2013 | 42 | 0.100 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 50 | 0.100 |
Why?
| | Cryoultramicrotomy | 1 | 2013 | 5 | 0.100 |
Why?
| | Decanoic Acids | 2 | 2005 | 8 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2014 | 205 | 0.100 |
Why?
| | Gelatin Sponge, Absorbable | 1 | 2012 | 5 | 0.100 |
Why?
| | Sulfhydryl Reagents | 1 | 2012 | 12 | 0.100 |
Why?
| | Developmental Biology | 1 | 2012 | 23 | 0.100 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2013 | 120 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 348 | 0.100 |
Why?
| | Wnt Proteins | 1 | 2013 | 135 | 0.100 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2012 | 45 | 0.100 |
Why?
| | Ethers | 1 | 2012 | 19 | 0.100 |
Why?
| | Connective Tissue Growth Factor | 1 | 2012 | 25 | 0.100 |
Why?
| | Biofouling | 1 | 2012 | 8 | 0.100 |
Why?
| | Fracture Healing | 1 | 2012 | 83 | 0.090 |
Why?
| | Systems Biology | 1 | 2012 | 69 | 0.090 |
Why?
| | Bone Transplantation | 1 | 2012 | 89 | 0.090 |
Why?
| | Crystallization | 2 | 2009 | 147 | 0.090 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 796 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 369 | 0.090 |
Why?
| | Receptor, EphA5 | 1 | 2011 | 1 | 0.090 |
Why?
| | Ephrin-A5 | 1 | 2011 | 1 | 0.090 |
Why?
| | China | 1 | 2012 | 214 | 0.090 |
Why?
| | Thermodynamics | 1 | 2013 | 423 | 0.090 |
Why?
| | Endoplasmic Reticulum | 1 | 2013 | 269 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1223 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 384 | 0.090 |
Why?
| | Half-Life | 1 | 2011 | 145 | 0.090 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2011 | 43 | 0.090 |
Why?
| | Biological Availability | 1 | 2011 | 134 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1311 | 0.080 |
Why?
| | Surface Plasmon Resonance | 1 | 2011 | 88 | 0.080 |
Why?
| | Homeostasis | 1 | 2014 | 618 | 0.080 |
Why?
| | Cell Physiological Phenomena | 1 | 2010 | 19 | 0.080 |
Why?
| | Heparin Lyase | 1 | 2010 | 5 | 0.080 |
Why?
| | Carbohydrate Sequence | 1 | 2010 | 28 | 0.080 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 22 | 0.080 |
Why?
| | Copper | 1 | 2011 | 110 | 0.080 |
Why?
| | Flow Cytometry | 2 | 2011 | 1194 | 0.080 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 597 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 1 | 2013 | 624 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2012 | 302 | 0.080 |
Why?
| | Foreskin | 1 | 2009 | 5 | 0.080 |
Why?
| | Ascorbic Acid | 1 | 2011 | 178 | 0.080 |
Why?
| | Polymethacrylic Acids | 2 | 2003 | 62 | 0.080 |
Why?
| | Enzyme Assays | 1 | 2009 | 26 | 0.080 |
Why?
| | Decorin | 1 | 2009 | 7 | 0.080 |
Why?
| | Lithium | 1 | 2009 | 44 | 0.080 |
Why?
| | Biochemical Phenomena | 1 | 2009 | 9 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2011 | 134 | 0.080 |
Why?
| | Cloning, Molecular | 1 | 2010 | 535 | 0.080 |
Why?
| | Acrylamides | 1 | 2009 | 58 | 0.080 |
Why?
| | Adrenal Glands | 1 | 2009 | 75 | 0.080 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2007 | 138 | 0.080 |
Why?
| | Keratinocytes | 1 | 2010 | 249 | 0.080 |
Why?
| | Biotechnology | 1 | 2009 | 45 | 0.080 |
Why?
| | Fibroblast Growth Factors | 1 | 2010 | 177 | 0.080 |
Why?
| | Culture Techniques | 1 | 2008 | 73 | 0.070 |
Why?
| | Amino Acid Motifs | 1 | 2009 | 224 | 0.070 |
Why?
| | Computer Simulation | 2 | 2013 | 987 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2121 | 0.070 |
Why?
| | Cysteine | 1 | 2010 | 203 | 0.070 |
Why?
| | Serum Albumin | 1 | 2009 | 150 | 0.070 |
Why?
| | Microchemistry | 1 | 2008 | 19 | 0.070 |
Why?
| | X-Ray Diffraction | 2 | 2005 | 104 | 0.070 |
Why?
| | Probability | 1 | 2009 | 308 | 0.070 |
Why?
| | Ultrasonics | 1 | 2008 | 48 | 0.070 |
Why?
| | Integrin alpha5beta1 | 1 | 2008 | 9 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 662 | 0.070 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2008 | 24 | 0.070 |
Why?
| | Integrin alphaVbeta3 | 1 | 2008 | 18 | 0.070 |
Why?
| | Microbial Sensitivity Tests | 1 | 2009 | 346 | 0.070 |
Why?
| | Surface-Active Agents | 1 | 2008 | 91 | 0.070 |
Why?
| | Fibrin | 1 | 2008 | 86 | 0.070 |
Why?
| | Lasers | 1 | 2008 | 130 | 0.070 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1146 | 0.070 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2009 | 3664 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2712 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2010 | 5769 | 0.070 |
Why?
| | Drug Stability | 2 | 2005 | 161 | 0.070 |
Why?
| | Aggrecans | 1 | 2007 | 15 | 0.070 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2007 | 25 | 0.070 |
Why?
| | Mitogens | 1 | 2007 | 59 | 0.070 |
Why?
| | Hepatocyte Growth Factor | 1 | 2007 | 35 | 0.070 |
Why?
| | Surgical Wound Infection | 1 | 2010 | 305 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 621 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 863 | 0.060 |
Why?
| | Calorimetry, Differential Scanning | 3 | 2005 | 37 | 0.060 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 55 | 0.060 |
Why?
| | Environment | 1 | 2008 | 339 | 0.060 |
Why?
| | Bioreactors | 1 | 2006 | 48 | 0.060 |
Why?
| | Griseofulvin | 1 | 2005 | 2 | 0.060 |
Why?
| | Water | 1 | 2009 | 468 | 0.060 |
Why?
| | Tetrazolium Salts | 1 | 2005 | 18 | 0.060 |
Why?
| | Stem Cell Transplantation | 1 | 2007 | 178 | 0.060 |
Why?
| | Nanotechnology | 1 | 2007 | 124 | 0.060 |
Why?
| | Calcium Phosphates | 1 | 2005 | 29 | 0.060 |
Why?
| | X-Ray Microtomography | 2 | 2019 | 97 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2007 | 315 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1049 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 1946 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 2125 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 818 | 0.060 |
Why?
| | Ear, External | 1 | 2005 | 21 | 0.060 |
Why?
| | Glucagon | 1 | 2005 | 105 | 0.060 |
Why?
| | Thiazoles | 1 | 2005 | 125 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2571 | 0.060 |
Why?
| | Facial Bones | 1 | 2005 | 30 | 0.060 |
Why?
| | Nasal Septum | 1 | 2005 | 25 | 0.060 |
Why?
| | Immunoblotting | 1 | 2005 | 306 | 0.060 |
Why?
| | Antigens, CD | 1 | 2008 | 530 | 0.060 |
Why?
| | Cell Count | 1 | 2005 | 318 | 0.060 |
Why?
| | Nose | 1 | 2005 | 65 | 0.060 |
Why?
| | Stress Fibers | 1 | 2004 | 19 | 0.060 |
Why?
| | Hexuronic Acids | 1 | 2004 | 23 | 0.060 |
Why?
| | Larynx | 1 | 2005 | 60 | 0.060 |
Why?
| | Glucuronic Acid | 1 | 2004 | 25 | 0.060 |
Why?
| | MCF-7 Cells | 1 | 2024 | 123 | 0.050 |
Why?
| | Methylation | 1 | 2025 | 228 | 0.050 |
Why?
| | Myofibrils | 1 | 2024 | 48 | 0.050 |
Why?
| | Sheep | 1 | 2007 | 853 | 0.050 |
Why?
| | Alginates | 1 | 2004 | 46 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2005 | 190 | 0.050 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2005 | 196 | 0.050 |
Why?
| | Photography | 1 | 2004 | 107 | 0.050 |
Why?
| | Cell Size | 1 | 2004 | 90 | 0.050 |
Why?
| | Postprandial Period | 1 | 2024 | 109 | 0.050 |
Why?
| | Immunity, Innate | 1 | 2009 | 826 | 0.050 |
Why?
| | Catalysis | 2 | 2017 | 317 | 0.050 |
Why?
| | Surgical Flaps | 1 | 2005 | 141 | 0.050 |
Why?
| | Viral Envelope Proteins | 1 | 2024 | 97 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1747 | 0.050 |
Why?
| | Trachea | 1 | 2005 | 249 | 0.050 |
Why?
| | Magnetic Phenomena | 1 | 2023 | 10 | 0.050 |
Why?
| | Gene Transfer Techniques | 1 | 2004 | 175 | 0.050 |
Why?
| | Cystatin C | 1 | 2022 | 65 | 0.050 |
Why?
| | Oxidation-Reduction | 3 | 2011 | 1075 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 1059 | 0.050 |
Why?
| | Somatomedins | 1 | 2002 | 27 | 0.050 |
Why?
| | Biomarkers, Pharmacological | 1 | 2022 | 26 | 0.050 |
Why?
| | Polyvinyls | 1 | 2002 | 21 | 0.050 |
Why?
| | Glycoproteins | 1 | 2024 | 357 | 0.050 |
Why?
| | Injections | 1 | 2002 | 187 | 0.050 |
Why?
| | Technology, Pharmaceutical | 1 | 2002 | 30 | 0.050 |
Why?
| | Subcutaneous Tissue | 1 | 2002 | 24 | 0.050 |
Why?
| | Paneth Cells | 1 | 2022 | 16 | 0.050 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 147 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2023 | 190 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2022 | 82 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2024 | 730 | 0.040 |
Why?
| | Cicatrix | 1 | 2022 | 66 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2003 | 310 | 0.040 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2001 | 86 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2010 | 6140 | 0.040 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2001 | 8 | 0.040 |
Why?
| | Chlorobenzenes | 1 | 2001 | 9 | 0.040 |
Why?
| | Succinimides | 1 | 2001 | 19 | 0.040 |
Why?
| | Receptors, Notch | 1 | 2022 | 89 | 0.040 |
Why?
| | Femur | 2 | 2019 | 256 | 0.040 |
Why?
| | Nucleic Acid Conformation | 1 | 2004 | 722 | 0.040 |
Why?
| | Polyglycolic Acid | 1 | 2001 | 44 | 0.040 |
Why?
| | Chromosomes | 1 | 2021 | 106 | 0.040 |
Why?
| | Adrenergic beta-Agonists | 1 | 2021 | 98 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 143 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 552 | 0.040 |
Why?
| | Lung | 1 | 2013 | 4065 | 0.040 |
Why?
| | Mathematical Computing | 1 | 2000 | 10 | 0.040 |
Why?
| | Fumarates | 1 | 2019 | 9 | 0.040 |
Why?
| | Polypropylenes | 1 | 2019 | 12 | 0.040 |
Why?
| | Gonadal Steroid Hormones | 1 | 2021 | 139 | 0.040 |
Why?
| | Ursidae | 1 | 2019 | 8 | 0.040 |
Why?
| | Muscles | 1 | 2001 | 331 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2000 | 143 | 0.040 |
Why?
| | Blood Proteins | 1 | 2001 | 246 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2006 | 1419 | 0.040 |
Why?
| | Models, Genetic | 1 | 2022 | 589 | 0.040 |
Why?
| | Spectrophotometry, Infrared | 1 | 1999 | 54 | 0.040 |
Why?
| | Intracellular Space | 1 | 2019 | 68 | 0.040 |
Why?
| | Lipids | 1 | 2003 | 681 | 0.040 |
Why?
| | Mitochondria | 1 | 2005 | 951 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2024 | 923 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 500 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2847 | 0.040 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2018 | 35 | 0.040 |
Why?
| | Drug Liberation | 1 | 2018 | 35 | 0.040 |
Why?
| | Prosthesis Implantation | 1 | 1999 | 152 | 0.030 |
Why?
| | Protein Transport | 1 | 2019 | 441 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2004 | 2799 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 946 | 0.030 |
Why?
| | Ketanserin | 1 | 1996 | 12 | 0.030 |
Why?
| | Quality Control | 1 | 1996 | 168 | 0.030 |
Why?
| | Genotype | 1 | 2021 | 1876 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1109 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 614 | 0.030 |
Why?
| | Sclerosis | 1 | 2014 | 11 | 0.030 |
Why?
| | Collagen Type III | 1 | 2014 | 17 | 0.030 |
Why?
| | Receptors, Wnt | 1 | 2013 | 2 | 0.030 |
Why?
| | Coatomer Protein | 1 | 2013 | 3 | 0.030 |
Why?
| | ras GTPase-Activating Proteins | 1 | 2013 | 15 | 0.030 |
Why?
| | Wnt-5a Protein | 1 | 2013 | 24 | 0.030 |
Why?
| | Exocytosis | 1 | 2014 | 89 | 0.030 |
Why?
| | Myosins | 1 | 2013 | 135 | 0.020 |
Why?
| | Cell Polarity | 1 | 2013 | 140 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2013 | 165 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2016 | 971 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 1996 | 468 | 0.020 |
Why?
| | Myocardial Infarction | 1 | 2019 | 1053 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 189 | 0.020 |
Why?
| | Algorithms | 1 | 1999 | 1711 | 0.020 |
Why?
| | Ear Cartilage | 1 | 2010 | 4 | 0.020 |
Why?
| | Skin | 2 | 2010 | 753 | 0.020 |
Why?
| | Integrin beta4 | 1 | 2010 | 1 | 0.020 |
Why?
| | Enzymes, Immobilized | 1 | 2011 | 30 | 0.020 |
Why?
| | Microtubules | 1 | 2013 | 280 | 0.020 |
Why?
| | Keratin-14 | 1 | 2010 | 15 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1751 | 0.020 |
Why?
| | Dermis | 1 | 2010 | 34 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 703 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2012 | 347 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 309 | 0.020 |
Why?
| | Physical Phenomena | 1 | 2009 | 13 | 0.020 |
Why?
| | Amino Acids | 1 | 2013 | 499 | 0.020 |
Why?
| | Dimerization | 2 | 1999 | 197 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 352 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 826 | 0.020 |
Why?
| | Buffers | 1 | 2007 | 56 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2007 | 113 | 0.020 |
Why?
| | Nanocomposites | 1 | 2007 | 14 | 0.020 |
Why?
| | Skull Fractures | 1 | 2007 | 38 | 0.020 |
Why?
| | Protons | 1 | 2007 | 91 | 0.020 |
Why?
| | Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.020 |
Why?
| | Chemical Precipitation | 1 | 2005 | 38 | 0.020 |
Why?
| | Powders | 1 | 2005 | 41 | 0.020 |
Why?
| | Excipients | 1 | 2005 | 54 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2007 | 396 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 10832 | 0.010 |
Why?
| | Solutions | 1 | 2004 | 169 | 0.010 |
Why?
| | DNA Replication | 1 | 2004 | 239 | 0.010 |
Why?
| | Models, Statistical | 1 | 2006 | 665 | 0.010 |
Why?
| | Patella | 1 | 2000 | 26 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1237 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 1999 | 161 | 0.010 |
Why?
| | Adhesiveness | 1 | 1996 | 20 | 0.010 |
Why?
| | Freezing | 1 | 1996 | 88 | 0.010 |
Why?
| | Mucins | 1 | 1996 | 73 | 0.010 |
Why?
|
|
Anseth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|